Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Bentsur Ron
Over the trailing 90 days, Bentsur Ron (Director at Nuvectis Pharma, Inc.) bought $250K of stock in NVCT, per 1 SEC Form 4 transaction.
- Role
- Director
- Companies
- NVCT
- Window
- Trailing 90 days · 1 transactions · CIK 1251213
- Net activity
- +$250K ($250K bought · $0 sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| NVCT | Nuvectis Pharma, Inc. | 1 | $250K | — | $250K |
Transactions (1)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-30 | NVCT | Buy | 12.5K | $250K | Open market or private purchase |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Bentsur's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.